Swedish Orphan Biovitrum Ab (BIOVF)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | BIOVF | ASND | PCVX | ||
| Company | Swedish Orphan Biovitrum Ab | Ascendis Pharma ADR | Vaxcyte Inc | ||
| Price Information | |||||
| Exchange | OTC US | NASDAQ | NASDAQ | ||
| Open | 25.7557 | 141.96 | 66.48 | ||
| High | 25.7557 | 142.36 | 67.08 | ||
| Low | 25.4110 | 135.16 | 65.46 | ||
| Last | 25.7557 | 137.20 | 65.96 | ||
| Change | +2.8857 | -3.90 | +1.41 | ||
| % Change | +12.62% | -2.76% | +2.18% | ||
| Volume | 4,000 | 511,400 | 620,600 | ||
| 20-Day Average Volume | 625 | 326,075 | 702,005 | ||
| Previous Close | 22.8700 | 141.10 | 64.55 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | No | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 25.2810 | 143.15 | 62.29 | ||
| 20-Day Raw Stochastic | 69.82% | 16.25% | 87.53% | ||
| 20-Day Relative Strength | 54.45% | 43.02% | 53.44% | ||
| Weighted Alpha | N/A | +47.34 | +30.76 | ||
| Today's Opinion | N/A | 24% Buy | 32% Buy | ||
| Previous Opinion | N/A | 40% Buy | 24% Buy | ||
| Last Month's Opinion | N/A | 88% Buy | 24% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | -5.20% since 03/08/24 | +0.96% since 04/26/24 | +8.63% since 04/26/24 | ||
| Low | 22.8700 on 04/18/24 | 135.16 on 05/03/24 | 58.84 on 04/30/24 | ||
| High | 27.7900 on 03/12/24 | 143.99 on 05/02/24 | 67.08 on 05/03/24 | ||
| 1-Month | |||||
| %Chg | +3.02% since 04/01/24 | -8.23% since 04/03/24 | +1.32% since 04/03/24 | ||
| Low | 22.8700 on 04/18/24 | 133.39 on 04/26/24 | 58.10 on 04/25/24 | ||
| High | 25.7557 on 05/03/24 | 156.84 on 04/10/24 | 67.08 on 05/03/24 | ||
| 3-Month | |||||
| %Chg | -4.61% since 01/23/24 | -1.84% since 02/02/24 | -12.37% since 02/02/24 | ||
| Low | 22.8700 on 04/18/24 | 133.39 on 04/26/24 | 58.10 on 04/25/24 | ||
| High | 27.7900 on 03/12/24 | 161.00 on 02/26/24 | 82.04 on 02/28/24 | ||
| 6-Month | |||||
| %Chg | +28.14% since 11/02/23 | +44.96% since 11/03/23 | +29.97% since 11/03/23 | ||
| Low | 21.0500 on 11/06/23 | 86.54 on 11/13/23 | 46.16 on 11/13/23 | ||
| High | 27.7900 on 03/12/24 | 161.00 on 02/26/24 | 82.04 on 02/28/24 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 7,602,053 | 7,988,331 | 7,150,591 | ||
| Shares Outstanding, K | 295,160 | 58,224 | 108,408 | ||
| Annual Sales | 2,086,200,000 | 288,670,000 | 0 | ||
| Annual Net Income | 227,170,000 | -521,070,000 | -402,270,000 | ||
| Last Quarter Sales | 601,910,000 | 148,660,000 | 0 | ||
| Last Quarter Net Income | 76,970,000 | -93,040,000 | -180,800,000 | ||
| 60-Month Beta | 0.53 | 0.54 | 0.94 | ||
| Per-Share Information | |||||
| Most Recent Earnings | 0.26 on 04/25/24 | -1.66 on 02/07/24 | -1.82 on 02/27/24 | ||
| Latest Earnings Date | 04/25/24 | 05/02/24 | 05/13/24 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 30.49 | 0.00 | 0.00 | ||